| Value | ₹56.82 Cr |
|---|
NSE filing, NSE: KILITCH. Summary written from the filing by ALFA Finder's alert engine.
Kilitch Drugs(I) Ltd: key numbers
- Share price
- ₹200.61
- Market cap
- ₹701.4 Cr
- Revenue (annual)
- ₹235.5 Cr
- Net profit (annual)
- ₹30.17 Cr
- P/E (TTM)
- 29.1×Sector 43.8×
- Promoter holding
- 63.77%+0.00% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kilitch Drugs(I) Ltd
All →Kilitch Drugs(I) Annual General Meeting
Kilitch Drugs corrected the explanatory statement for its EGM on 16 November 2026, changing additional KEB shares from 1,66,472 to 1,66,471. The corrigendum also restates the USD 12,855,000 KEB Sale consideration.
Kilitch Drugs(I) Q2 FY27 Results: Net Profit ₹1.4 Cr, Down 82.5% YoY
Kilitch Drugs(I) Ltd reported revenue from operations of ₹50.2 Cr (+2.7% YoY) and net profit of ₹1.4 Cr (-82.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.4 Cr · -82.5% YoY
Kilitch Drugs(I) Board Meeting Date
Kilitch Drugs will hold a board meeting on 6 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after disclosure.
Kilitch Drugs(I) Annual General Meeting
Kilitch Drugs' EGM notice seeks shareholder approval for selling its Ethiopian material subsidiary and converting subsidiary debt into equity. It also proposes two independent director appointments.
Kilitch Drugs(I) Merger & Restructuring Worth ₹131.6 Cr
Kilitch Drugs will divest its entire Ethiopian subsidiary stake to HarmeeCare for US$14 million (~₹131.6 Crore). Proceeds will fund debt repayment and Pen plant expansion.
- Value
- ₹131.6 Cr
Kilitch Drugs(I) Merger & Restructuring Worth ₹120.8 Cr
Kilitch Drugs will divest its 100% stake in subsidiary Kilitch Estro Biotech PLC for USD 12.855 million (approx. ₹120.84 Crore).
- Value
- ₹120.8 Cr
- From
- HarmeeCare Pharmaceuticals
Other acquisition announcements
All →Baazar Style Retail Acquisition Worth ₹0.01 Cr
Baazar Style Retail's subsidiary-level acquisition of Sunright Private Limited for Rs.0.01 Crore cash, a related-party deal for solar power generation. Promoter group and KMP are directors of the target.
- Value
- ₹0.01 Cr
One Global Service Provider Acquisition
One Global Service Provider completed acquisition of 51% stakes in Matrix Labs Diagnocare Pvt Ltd and Matrix Labs Pvt Ltd, both now subsidiaries. The acquisition was settled via consideration other than cash.
Arkade Developers Acquisition Worth ₹0.01 Cr
Arkade Developers Limited subscribed 100% of the initial paid-up capital of newly incorporated Arkade Estates Private Limited, a real estate arm, for Rs.1,00,000 in cash. The subsidiary has not yet commenced business operations.
- Value
- ₹0.01 Cr
Mudunuru Acquisition Worth ₹0.05 Cr
Mudunuru Limited will acquire 51% equity of Mudunuru Hospitality Private Limited for cash, a related-party-linked deal. Cost is Rs.0.05 Crore, with completion targeted by 31-12-2026.
- Value
- ₹0.05 Cr
- Execution
- Indicative completion by 31-12-2026
Aeroflex Enterprises Acquisition Worth ₹31 Cr
Aeroflex Neu, a material subsidiary, completed the acquisition of 55% of Aerolex Cables for ₹31 Crore. Aerolex becomes a subsidiary, with further tranches to follow.
- Value
- ₹31.00 Cr
Aeroflex Neu Acquisition Worth ₹31 Cr
Aeroflex Neu completed buying 1,10,000 Aerolex Cables shares for Rs. 31 Crore today. Aerolex becomes a 55% subsidiary, entering wire and cable manufacturing.
- Value
- ₹31.00 Cr